Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

58364 1487845784HCLSReviewSingaporeFeb2017.pdf
Energy Boardroom

Sanofi Japan sees growth for new products but generics bite

03.04.2014 / Scripintelligence

However, generic competition hit Allegra (fexofenadine; -18% to JPY47.1bn) and Myslee (zolpidem; -14% to JPY32bn).

Cover_HCLS_Singapore LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: